Divi's Laboratories Ltd.

NSE: DIVISLAB | BSE: 532488 | ISIN: INE361B01024 | Industry: Pharmaceuticals
| Expensive Performer
5914.5000 -217.00 (-3.54%)
NSE Aug 08, 2025 15:31 PM
Volume: 541.4K
 

5914.50
-3.54%
Phillip Capital
finetuned our FY16/FY17 EPS estimates to Rs 77.8/92.4, 2.9%/2.4% higher than before. We now value the company at Rs 1,940, 21x FY17 EPS, vs. Rs 1,900 earlier. Due to the limited upside potential (5%), we retain our NEUTRAL rating. The company's 80%+...
Divi's Laboratories .. has an average target of 6447.40 from 5 brokers.
More from Divi's Laboratories Ltd.
More from Suhani Adilabadkar
Recommended